載入...
When to start: as soon as possible
Debate regarding “When to start” antiretroviral (ARV) therapy has raged since the introduction of zidovudine in 1987. Based on the entry criteria for the original Burroughs Wellcome (002) study, the field has been anchored to “CD4 counts” as the prime metric to indicate ARV treatment initiation for...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
International AIDS Society
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3512539/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.15.6.18070 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|